首页 >
法规速递
-
Page: EudraVigilance training and support-2025/2/6
2025-02-10查看详情 > -
Page: Frequently asked questions-2025/3/14
2025-03-17查看详情 > -
Page: Fees payable to the European Medicines Agency-2025/4/15
2025-04-16查看详情 > -
《麻醉药品和精神药品实验研究管理规定》政策解读 -2025/5/30
2025-05-30查看详情 > -
Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment-2025/7/2
2025-07-03查看详情 > -
Document: Concept paper on the need for revision of the guideline on the clinical investigation of medicines for the treatment of Alzheimer's disease-2025/8/6
2025-08-06查看详情 > -
Document: Timetable: Post-authorisation measure (PAM) assessed by CHMP-2025/9/24
2025-09-25查看详情 > -
Page: PRIME: priority medicines-2025/10/31
2025-11-03查看详情 > -
Document: Concept paper on the need for revision of the guideline on clinical investigation of medicinal products in the treatment of Parkinson’s disease-2025/12/1
2025-12-02查看详情 > -
Page: Emergency Task Force (ETF)-2026/1/5
2026-01-06查看详情 >
